Insmed Incorporated (DUS:IM8N) Financings

Insmed Incorporated

Financings

RaiseDate
Public offering of common stock
Announced: about US$750M · US$96 a share · Goldman Sachs & Co. LLC +5
Dealers: Goldman Sachs & Co. LLC (lead), Leerink Partners (lead), BofA Securities (lead), Jefferies (lead), J.P. Morgan (lead), Stifel (co-lead)
Use of proceeds: R&D and commercialization of brensocatib, ARIKAYCE commercialization and development, TPIP, INS1201 and pre-clinical research, and general corporate purposes
Jun 11, 2025
Public offering of common stock
Announced: US$650M · Goldman Sachs & Co. LLC +1
Dealers: Goldman Sachs & Co. LLC (co-lead), Leerink Partners (co-lead)
Jun 11, 2025

Read by 6ix AI from the company's releases